Target
Cytochrome P450 1A2
Ligand
BDBM319585
Substrate
n/a
Meas. Tech.
ChEMBL_2022220 (CHEMBL4676033)
IC50
>100000±n/a nM
Citation
 Futatsugi, KSmith, ACTu, MRaymer, BAhn, KCoffey, SBDowling, MSFernando, DPGutierrez, JAHuard, KJasti, JKalgutkar, ASKnafels, JDPandit, JParris, KDPerez, SPfefferkorn, JAPrice, DARyder, TShavnya, AStock, IATsai, ASTesz, GJThuma, BAWeng, YWisniewska, HMXing, GZhou, JMagee, TV Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose. J Med Chem 63:13546-13560 (2020) [PubMed]  Article 
Target
Name:
Cytochrome P450 1A2
Synonyms:
CP1A2_HUMAN | CYP1A2 | CYPIA2 | Cholesterol 25-hydroxylase | Cytochrome P(3)450 | Cytochrome P450 1A | Cytochrome P450 1A2 (CYP1A2) | Cytochrome P450 4 | Cytochrome P450-P3
Type:
Enzyme
Mol. Mass.:
58423.38
Organism:
Homo sapiens (Human)
Description:
P05177
Residue:
516
Sequence:
MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPLLGHVLTLGKNPHLALSRMSQRYGDVLQIRIGSTPVLVLSRLDTIRQALVRQGDDFKGRPDLYTSTLITDGQSLTFSTDSGPVWAARRRLAQNALNTFSIASDPASSSSCYLEEHVSKEAKALISRLQELMAGPGHFDPYNQVVVSVANVIGAMCFGQHFPESSDEMLSLVKNTHEFVETASSGNPLDFFPILRYLPNPALQRFKAFNQRFLWFLQKTVQEHYQDFDKNSVRDITGALFKHSKKGPRASGNLIPQEKIVNLVNDIFGAGFDTVTTAISWSLMYLVTKPEIQRKIQKELDTVIGRERRPRLSDRPQLPYLEAFILETFRHSSFLPFTIPHSTTRDTTLNGFYIPKKCCVFVNQWQVNHDPELWEDPSEFRPERFLTADGTAINKPLSEKMMLFGMGKRRCIGEVLAKWEIFLFLAILLQQLEFSVPPGVKVDLTPIYGLTMKHARCEHVQARLRFSIN
  
Inhibitor
Name:
BDBM319585
Synonyms:
US10174007, Example 4 | US10787438, Example 4 | US10988463, Example 4 | US11634410, Example 4
Type:
Small organic molecule
Emp. Form.:
C16H19F3N4O2
Mol. Mass.:
356.3429
SMILES:
C[C@H]1CCN1c1nc(cc(n1)C(F)(F)F)N1C[C@H]2[C@H](CC(O)=O)[C@H]2C1 |r|
Structure:
Search PDB for entries with ligand similarity: